Published in Clin Cosmet Investig Dermatol on March 18, 2016
Rosacea: Molecular Mechanisms and Management of a Chronic Cutaneous Inflammatory Condition. Int J Mol Sci (2016) 0.75
The Burden of Illness of Erythematotelangiectatic Rosacea and Papulopustular Rosacea: Findings From a Web-based Survey. J Clin Aesthet Dermatol (2017) 0.75
Interventions for rosacea: abridged updated Cochrane systematic review including GRADE assessments. Br J Dermatol (2015) 2.08
A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial. Arch Dermatol (2003) 1.92
Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea. Cutis (2006) 1.64
Temperature regulates bacterial protein production: possible role in rosacea. J Am Acad Dermatol (2004) 1.55
Epithelial barrier function and atopic diathesis in rosacea and perioral dermatitis. Br J Dermatol (2004) 1.09
Cathelicidin, kallikrein 5, and serine protease activity is inhibited during treatment of rosacea with azelaic acid 15% gel. J Am Acad Dermatol (2013) 1.08
New insights into rosacea pathophysiology: a review of recent findings. J Am Acad Dermatol (2013) 1.06
Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies. J Am Acad Dermatol (2003) 1.06
Potential role of Demodex mites and bacteria in the induction of rosacea. J Med Microbiol (2012) 1.04
Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies. J Drugs Dermatol (2014) 0.96
Papulopustular rosacea, skin immunity and Demodex: pityriasis folliculorum as a missing link. J Eur Acad Dermatol Venereol (2011) 0.93
Superiority of ivermectin 1% cream over metronidazole 0·75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial. Br J Dermatol (2015) 0.92
Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors. J Am Acad Dermatol (2015) 0.92
A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy. J Drugs Dermatol (2009) 0.89
Azelaic acid foam 15% in the treatment of papulopustular rosacea: a randomized, double-blind, vehicle-controlled study. Cutis (2013) 0.87
A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea. J Am Acad Dermatol (1999) 0.87
Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trials. J Drugs Dermatol (2014) 0.86
Azelaic acid 15% gel once daily versus twice daily in papulopustular rosacea. J Drugs Dermatol (2008) 0.85
The CLEAR trial: results of a large community-based study of metronidazole gel in rosacea. Cutis (2007) 0.85
Treatment of rosacea-like demodicidosis with oral ivermectin and topical permethrin cream. J Am Acad Dermatol (1999) 0.85
Emerging therapies in rosacea. J Am Acad Dermatol (2013) 0.85
The potential role of microorganisms in the development of rosacea. J Dtsch Dermatol Ges (2010) 0.85
Gnatophyma--a rare form of rosacea. An Bras Dermatol (2012) 0.84
The role of Helicobacter pylori infection in skin diseases: facts and controversies. Clin Dermatol (2010) 0.84
Rosacea: part II. Topical and systemic therapies in the treatment of rosacea. J Am Acad Dermatol (2015) 0.84
An emerging treatment: Topical ivermectin for papulopustular rosacea. J Dermatolog Treat (2015) 0.82
The efficacy of metronidazole 1% cream once daily compared with metronidazole 1% cream twice daily and their vehicles in rosacea: a double-blind clinical trial. J Am Acad Dermatol (1998) 0.81
Patterns of ambulatory care usage and leading treatments for rosacea. J Dermatolog Treat (2014) 0.80
Topical metronidazole therapy for rosacea. Arch Dermatol (1987) 0.80
Crusted demodicosis in an immunocompetent pediatric patient. Case Rep Dermatol Med (2014) 0.80
Topical metronidazole. A review of its use in rosacea. Am J Clin Dermatol (2001) 0.79
Recalcitrant papulopustular rosacea in an immunocompetent patient responding to combination therapy with oral ivermectin and topical permethrin. Cutis (2007) 0.79
Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea. J Am Acad Dermatol (2001) 0.79
The pathophysiology of rosacea. G Ital Dermatol Venereol (2009) 0.79
Rosacea: new and emerging treatments. Drugs (2014) 0.79
Assessment of rosacea severity: A review of evaluation methods used in clinical trials. J Am Acad Dermatol (2015) 0.77
Ivermectin cream (Soolantra) for rosacea. Med Lett Drugs Ther (2015) 0.77
The treatment of rosacea with topical ivermectin. Drugs Today (Barc) (2015) 0.76
Severe demodexfolliculorum-associated oculocutaneous rosacea in a girl successfully treated with ivermectin. JAMA Dermatol (2014) 0.76
Therapeutic update on Rosacea. J Drugs Dermatol (2014) 0.76